相关实验视频

Updated: Jun 26, 2026

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators
08:54

Human In-Vivo Bioassay for the Tissue-Specific Measurement of Nociceptive and Inflammatory Mediators

Published on: December 1, 2008

10.3K

使用微核测试对无疼痛药提取物进行体内基因毒性评估

Ji Hye Hwang1, Chul Jung2

  • 1Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University, Seongnam, Republic of Korea.

Journal of pharmacopuncture
|January 1, 2024
PubMed
概括

在微核试验中,无疼痛药理处方 (NPP) 在大鼠骨髓细胞中没有表现出基因毒性. 建议对这种肌肉放松和止痛剂进行进一步的毒性研究.

关键词:
穆通的药疗法是药.基因毒性测试 基因毒性测试在体内进行微核试验.没有疼痛的药物注射.在安全方面,安全是安全的.毒性的毒性 毒性的毒性

更多相关视频

An Automated Method to Perform The In Vitro Micronucleus Assay using Multispectral Imaging Flow Cytometry12:56

An Automated Method to Perform The In Vitro Micronucleus Assay using Multispectral Imaging Flow Cytometry

Published on: May 13, 2019

22.5K
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.8K

相关概念视频

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...